The Effects Of Combination Therapy With Dutasteride Plus Tamsulosin ...

Clipboard, Search History, and several other advanced features are temporarily unavailable. Skip to main page content

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search: Search Advanced Clipboard Save Email Send to

• Clipboard
• My Bibliography
• Collections
• Citation manager

Display options Display options Format Abstract PubMed PMID

Save citation to file

Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel

Email citation

Email address has not been verified. Go to My NCBI account settings to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel

Add to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error Please try again Add Cancel

Add to My Bibliography

• My Bibliography

Unable to load your delegates due to an error Please try again Add Cancel

Your saved search

Name of saved search: Search terms: Test search terms Would you like email updates of new search results? Saved Search Alert Radio Buttons

• Yes
• No

Email: (change) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel

Create a file for external citation management software

Create file Cancel

Your RSS Feed

Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy

Full text links

Nature Publishing Group Full text links

Actions

CiteCollectionsAdd to Collections

• Create a new collection
• Add to an existing collection

Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an errorPlease try again Add Cancel PermalinkPermalinkCopyDisplay options Display options Format AbstractPubMedPMID

Page navigation

• Title & authors
• Abstract
• Publication types
• MeSH terms
• Substances
• LinkOut - more resources

Title & authors Abstract Publication types MeSH terms Substances LinkOut - more resources Full text links CiteDisplay options Display options Format AbstractPubMedPMID

Abstract

CombAT (Combination of Avodart and Tamsulosin) was a randomised, double-blind study in men (n=4844) aged ≥ 50 years with a clinical diagnosis of BPH. Patients were randomised to daily tamsulosin 0.4 mg, dutasteride 0.5 mg or both for 4 years. The primary endpoint was time to acute urinary retention (AUR) or BPH-related surgery. Secondary endpoints included BPH clinical progression, symptoms and maximum urinary flow rate. A post hoc analysis of data from the European subgroup was conducted. A total of 2925 men were randomised to treatment in Europe as part of CombAT (tamsulosin, n=972; dutasteride, n=970; combination, n=983). Combination therapy significantly reduced the relative risk of AUR or BPH-related surgery compared with either monotherapy at 4 years, and also significantly reduced the risk of BPH clinical progression. Combination therapy also provided significantly greater symptom improvement than either monotherapy at 4 years. Safety and tolerability of dutasteride plus tamsulosin was consistent with previous experience of this combination and with the monotherapies. These data provide further evidence to support the use of long-term combination therapy (dutasteride plus tamsulosin) in men with moderate-to-severe lower urinary tract symptoms because of BPH and prostatic enlargement. The results in the European subgroup are generally consistent with those in the overall study population.

PubMed Disclaimer

Publication types

• Randomized Controlled Trial Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Research Support, Non-U.S. Gov't Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

MeSH terms

• 5-alpha Reductase Inhibitors / adverse effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• 5-alpha Reductase Inhibitors / therapeutic use* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Adrenergic alpha-1 Receptor Antagonists / adverse effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Adrenergic alpha-1 Receptor Antagonists / therapeutic use* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Aged Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Azasteroids / adverse effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Azasteroids / therapeutic use* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Disease Progression Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Drug Therapy, Combination Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Dutasteride Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Humans Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Male Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Middle Aged Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Prostatic Hyperplasia / complications Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Prostatic Hyperplasia / drug therapy* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Prostatic Hyperplasia / surgery Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Severity of Illness Index Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Sulfonamides / adverse effects Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Sulfonamides / therapeutic use* Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Tamsulosin Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Treatment Outcome Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Urinary Retention / etiology Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

Substances

• 5-alpha Reductase Inhibitors Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Adrenergic alpha-1 Receptor Antagonists Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Azasteroids Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Sulfonamides Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Tamsulosin Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search
• Dutasteride Actions
  • Search in PubMed
  • Search in MeSH
  • Add to Search

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Medical

  • ClinicalTrials.gov
  • MedlinePlus Health Information

Full text links [x] Nature Publishing Group [x] Cite Copy Download .nbib .nbib Format: AMA APA MLA NLM Send To

• Clipboard
• Email
• Save
• My Bibliography
• Collections
• Citation Manager

[x]

NCBI Literature Resources

MeSH PMC Bookshelf Disclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.